- Arteris Director Trims a Stake He's Been Selling All Year
May 10, 2026
Director Sells AIP 20,000 Shares for $601,000
Known for its semiconductor interconnect IP, this tech firm reported a sale by a board member amid ongoing reductions in executive holdings.
Antonio J Viana, Director of Arteris(NASDAQ:AIP), disclosed the sale of 20,000 shares for a transaction value of approximately $601,000 on May 5, 2026, according to a SEC Form 4 filing.
Transaction summary
Metric Value Shares sold (indirect) 20,000 Transaction value $601,000 Post-transaction shares (direct) 20,840 Post-transaction shares (indirect) 104,620
Transaction value based on SEC Form 4 reported price ($30.07); post-transaction value based on May 5, 2026 market close ($30.13).
Key questions
How does this sale compare to Antonio J Viana's historical selling patterns?
Viana's recent sales consistently involved blocks of 20,000 shares, and this transaction matches the maximum trade size observed in prior filings, indicating a continuation of established execution size as his aggregate holdings diminished. What is the ownership structure following this transaction?
After the sale, Viana maintains 20,840 shares via direct ownership and 104,620 shares through the Viana Family Trust, leaving him with a total of 125,460 shares across both categories. What portion of Viana's holdings was affected, and does the transaction represent a material shift?
The sale represented 16.05% of his indirect holdings and 13.75% of his total position, marking a meaningful reduction but not a full disposition; ongoing sales have tracked declining capacity rather than a change in strategy. Was the transaction part of a pre-arranged plan or discretionary?
The sale was executed under a Rule 10b5-1 trading plan adopted on June 10, 2025, indicating the trade was scheduled in advance and not a discretionary or opportunistic transaction.
Company overview
Metric Value Price (as of market close May 5, 2026) $30.07 Market capitalization $1.47 billion Revenue (TTM) $70.58 million 1-year price change N/A
* 1-year price change calculated using May 5, 2026 as the reference date.
Company snapshot
Offers semiconductor interconnect IP products including FlexNoC, Ncore, CodaCache, and deployment software solutions for SoC and NoC design. Generates revenue through licensing of intellectual property and software tools to enable efficient and scalable chip design. Serves customers across automotive, AI/machine learning, 5G/wireless, data centers, and consumer electronics markets globally.
Arteris is a leading provider of semiconductor interconnect intellectual property and deployment solutions, enabling efficient and scalable system-on-chip designs for a global customer base. The company's technology is embedded in critical applications across automotive, AI, and communications, supporting next-generation chip architectures. With a focus on innovation and silicon-proven IP, Arteris maintains a competitive edge in high-growth semiconductor markets.
Story Continues
What this transaction means for investors
TMF Writers add your take here...
Should you buy stock in Arteris right now?
Before you buy stock in Arteris, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Arteris wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $471,827!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,319,291!*
Now, it’s worth noting Stock Advisor’s total average return is 986% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of May 10, 2026.
Seena Hassouna has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Arteris Director Trims a Stake He's Been Selling All Year was originally published by The Motley Fool
View Comments
- Arteris Director Trims a Stake He's Been Selling All Year
May 10, 2026 · fool.com
Known for its semiconductor interconnect IP, this tech firm reported a notable insider sale amid ongoing reductions in executive holdings.
- Palantir Stock Falls Despite Earnings Beat, Government Strength
May 5, 2026 · zacks.com
Softer-than-expected U.S. commercial revenues appeared to outweigh raised sales guidance.
- Arteris Wins Stevie Award for Technology Innovation of the Year
Apr 30, 2026 · globenewswire.com
CAMPBELL, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced that its Cycuity Radix technology has been named the winner of a Bronze Stevie® Award in The 2026 American Business Awards® for Technology Innovation of the Year in the Software category.
- ARTERIS WINS STEVIE AWARD FOR TECHNOLOGY INNOVATION OF THE YEAR
Apr 30, 2026
CAMPBELL, CALIF., APRIL 30, 2026 (GLOBE NEWSWIRE) -- ARTERIS, INC. (NASDAQ: AIP), A LEADING PROVIDER OF SEMICONDUCTOR TECHNOLOGY FOR ACCELERATING INNOVATION IN THE AI ERA, TODAY ANNOUNCED THAT ITS CYCUITY RADIX TECHNOLOGY HAS BEEN NAMED THE WINNER OF A BRONZE STEVIE® AWARD IN THE 2026 AMERICAN BUSINESS AWARDS® FOR TECHNOLOGY INNOVATION OF THE YEAR IN THE SOFTWARE CATEGORY.
- Arteris (AIP) Is Up 8.8% After Deepening RISC-V AI Partnership With MIPS - Has The Bull Case Changed?
Apr 29, 2026
In April 2026, Arteris, Inc. announced an expanded collaboration with MIPS, a GlobalFoundries company, which will integrate Arteris FlexGen smart NoC IP and Magillem SoC integration automation software into MIPS’ RISC-V–based platforms for physical AI applications across automotive MCUs, ADAS, robotics, and embedded computing. This move effectively embeds Arteris’ system IP deeper into a major processor ecosystem, potentially making its technology a foundational element in future AI-enabled SoC designs across multiple high-growth use cases. Next, we’ll examine how embedding Arteris FlexGen NoC IP into MIPS’ RISC-V platforms could influence the company’s long-term investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
Arteris Investment Narrative Recap
To own Arteris, you need to believe its network-on-chip and SoC integration IP can become a core part of future AI-centric chip design, even as the company remains unprofitable and carries a rich valuation. The MIPS collaboration deepens Arteris’ presence in RISC V physical AI platforms, which could support the near term revenue story, but it does not remove the key risk that high operating costs and persistent losses could weigh on the stock if growth disappoints.
Among recent developments, the AMD FlexGen chiplet licensing deal stands out as especially relevant, because it showcased Arteris’ ability to plug into a major processor ecosystem before the MIPS announcement. Together, these relationships highlight both the main catalyst, which is wider adoption of Arteris IP across leading AI and chiplet platforms, and the parallel risk that heavy reliance on a few “whale” customers could amplify revenue volatility if any big contract changes course.
Yet beneath the AI excitement, investors should be aware that Arteris still faces...
Read the full narrative on Arteris (it's free!)
Arteris' narrative projects $103.2 million revenue and $13.5 million earnings by 2028. This requires 17.7% yearly revenue growth and a $46.6 million earnings increase from $-33.1 million today.
Uncover how Arteris' forecasts yield a $20.25 fair value, a 21% downside to its current price.
Exploring Other PerspectivesAIP 1-Year Stock Price Chart
While the MIPS deal points to wider AI adoption, the most cautious analysts still see risk that heavy R&D and customer concentration cap earnings, even if revenue reaches about US$137.1 million by 2029.
Explore 4 other fair value estimates on Arteris - why the stock might be worth less than half the current price!
Story Continues
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
A great starting point for your Arteris research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision. Our free Arteris research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arteris' overall financial health at a glance.
Contemplating Other Strategies?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation. Find 53 companies with promising cash flow potential yet trading below their fair value. Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AIP.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- An Arteris Director Sold Company Shares Worth $2 Million. Here's What That Means for Investors.
Apr 28, 2026
Saiyed Atiq Raza, a member of the Board of Directors at Arteris, Inc.(NASDAQ:AIP), reported the indirect sale of 90,000 shares for a total of approximately $1.99 million across multiple open-market transactions on April 17 and April 20, 2026, according to a SEC Form 4 filing.
Transaction summary
Metric Value Shares sold (indirect) 90,000 Transaction value $2.0 million Post-transaction shares (direct) 20,839 Post-transaction shares (indirect) 300,000 Post-transaction value (direct ownership) ~$472K
Transaction value based on SEC Form 4 weighted average purchase price ($22.16); post-transaction value based on April 20, 2026 market close ($22.63).
Key questions
How does this transaction compare to Saiyed Atiq Raza's historical selling patterns?
With a mean sell trade size of ~43,500 shares over 13 historical sales, this 90,000-share sale is more than double the average and consistent with a pattern of larger disposition events as remaining holdings decline. What proportion of indirect holdings was sold, and what does this indicate about remaining capacity?
The 90,000 shares sold represent 23.08% of the trust's pre-transaction indirect holdings, leaving 300,000 shares; this shrinking inventory suggests future sales may be smaller in absolute terms due to limited capacity. What is the market context for this activity?
Shares were sold at $22.16 per share, while the stock has appreciated 287.5% over the past year, providing a favorable window for liquidity events. Does the transaction signal any change in direct ownership?
Directly held shares remained essentially flat (20,839 after the transaction), indicating that the disposition was entirely indirect and did not affect the insider's direct stake.
Company overview
Metric Value Price (as of market close 2026-04-20) $22.63 Market capitalization $1.2 billion Revenue (TTM) $70.58 million 1-year price change 287.5%
* 1-year price change calculated using April 20th, 2026 as the reference date.
Company snapshot
Arteris develops and licenses semiconductor interconnect IP and deployment software, including FlexNoC, Ncore, and CodaCache, for use in System-on-Chip (SoC) designs. It generates revenue primarily through licensing and supporting its proprietary IP and software solutions to semiconductor and electronics manufacturers. The company serves customers in automotive, AI/machine learning, 5G/wireless, data centers, and consumer electronics sectors worldwide.
Arteris, Inc. operates as a specialized provider of interconnect IP and deployment solutions critical to modern semiconductor design, enabling faster and more efficient chip development.
Story Continues
The company leverages a scalable licensing model, supporting a diversified client base across high-growth technology markets. Its focus on advanced SoC and NoC architectures positions Arteris as a key enabler for innovation in automotive, AI, and communications applications.
What this transaction means for investors
The April 17 and 20 sale of Arteris stock by Board of Directors member Saiyed Atiq Raza is not a cause for concern for investors. The transaction was executed as part of a Rule 10b5-1 trading plan adopted in November of 2025. Such plans are often implemented by insiders to avoid accusations of making trades based on insider information.
Raza’s sale came at a time when Arteris stock was skyrocketing. Shares hit a 52-week high of $27 on April 24, just days after his disposition.
Arteris stock is hot thanks to artificial intelligence. Its products have become in demand with the rise of AI, resulting in 2025 sales soaring 22% year over year to $70.6 million. Despite the revenue growth, the company is not profitable, suffering a net loss of $34.7 million last year.
With its stock up, Arteris shares are expensive, as evidenced by a price-to-sales ratio of 16. This suggests now is a good time to sell, but not to buy.
Should you buy stock in Arteris right now?
Before you buy stock in Arteris, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Arteris wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $492,752!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,327,935!*
Now, it’s worth noting Stock Advisor’s total average return is 991% — a market-crushing outperformance compared to 201% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of April 28, 2026.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
An Arteris Director Sold Company Shares Worth $2 Million. Here's What That Means for Investors. was originally published by The Motley Fool
View Comments
- Arteris (AIP) Soars 9.9%: Is Further Upside Left in the Stock?
Apr 27, 2026
Arteris, Inc. AIP shares ended the last trading session 9.9% higher at $26.72. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 38.8% gain over the past four weeks.
The optimism surrounding the stock can be attributed to strong demand for Arteris’ semiconductor design IP solutions, supported by rising AI-driven chip development across data centers, automotive, consumer electronics and edge devices. The company is benefiting from strong adoption of its FlexGen AI-driven Smart NoC product, which has been licensed for more than 30 production deployments, futher strengthens the company's growth outlook.
This company is expected to post quarterly loss of $0.08 per share in its upcoming report, which represents a year-over-year change of +11.1%. Revenues are expected to be $21.1 million, up 27.7% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Arteris, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AIP going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Arteris is a member of the Zacks Internet - Software industry. One other stock in the same industry, Astera Labs, Inc. ALAB, finished the last trading session 7.8% higher at $212.84. ALAB has returned 73.9% over the past month.
For Astera Labs, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.54. This represents a change of +63.6% from what the company reported a year ago. Astera Labs, Inc. currently has a Zacks Rank of #3 (Hold).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Arteris, Inc. (AIP) : Free Stock Analysis Report
Astera Labs, Inc. (ALAB) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
- Arteris (AIP) Soars 9.9%: Is Further Upside Left in the Stock?
Apr 27, 2026 · zacks.com
Arteris (AIP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Arteris to Announce Financial Results for the First Quarter 2026 on Tuesday, May 12, 2026
Apr 22, 2026
CAMPBELL, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Tuesday, May 12, 2026.
Management will host a conference call on Tuesday, May 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing:
United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865
Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations.
A replay of the webcast will be available on the Events and Presentations page in the Investor Relations section of the company’s website approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.
About Arteris
Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world’s top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.
© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.
Investor Contacts
Arteris Inc.
Nick Hawkins
Chief Financial Officer
ir@arteris.com
Sapphire Investor Relations, LLC
Erica Mannion or Mike Funari
ir@arteris.com
+1-617-542-6180
